Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6279
Gene Symbol: S100A8
S100A8
0.050 Biomarker disease BEFREE Histology revealed the presence of infection in 68% of cases of mild/chronic nonspecific gastritis with others belonging to the GU sequel. cagA gene carriage was observed in 104 (51%) cases or mostly from DU, GU and GC groups, of which 97 were Western type strains while 3 were East-Asian type strains that are rarely observed in South Asia. vacA allelic variant s1am1 was most commonly observed, followed by s1am2, and s1bm1, with direct correlation in diseased cases (gastritis, GU, DU and GC). 23493000 2013
Entrez Id: 6279
Gene Symbol: S100A8
S100A8
0.050 Biomarker disease BEFREE CagA gene was positively associated with DU and GU (P<0.01, P<0.02), but not with NUD (P>0.05). 12854168 2003
Entrez Id: 6279
Gene Symbol: S100A8
S100A8
0.050 GeneticVariation disease BEFREE Since allelic variation in cagA exists and distinct H. pylori subgenotypes may circulate in different regions, PCR using primers for a variable 3' region of the cagA gene according to a Japanese methodology and for a consensus cagA 3' region used in Western methods was used for cagA detection. cagA was present in 53 (71%) of 75 H. pylori-positive cases when analyzed by the consensus region method and was associated with duodenal ulcer disease (P = 0.02), but not with gastric ulcer (P = 0.26), when compared to patients with duodenitis or gastritis. 11158115 2001
Entrez Id: 6279
Gene Symbol: S100A8
S100A8
0.050 Biomarker disease BEFREE The cagA gene was present in 94-97% of subjects in all categories, but the cagA antibody was less prevalent in nonulcer dyspepsia (69%, 95% CI: 48-86%, p = 0.02) and GERD (69%, CI: 39-91%, p < 0.05) than in those with gastroduodenal pathology including gastric ulcer, duodenal ulcer, and gastric cancer (92%, CI: 81-98%). 10710054 2000
Entrez Id: 6279
Gene Symbol: S100A8
S100A8
0.050 GeneticVariation disease BEFREE The prevalence of cagA gene determined by the first, and second primers was 90.9% (20/22), 90.9% (20/22) in strains from GU, 87.0% (20/23), 91.3% (21/23) from DU, and 86.2% (25/29), 89.7% (26/29) from CG patients, respectively. 10352081 1999